Slingshot members are tracking this event:
Global Blood Therapeutics Receives FDA Orphan Drug Designation for GBT440 in Sickle Cell Disease
Slingshot Insights Explained
Dec 31, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Fda, Orphan Drug, Orphan Treatment Designation, Gbt440, Sickle Cell Disease